Universal Health Services (UHS)
(Delayed Data from NYSE)
$153.65 USD
-6.38 (-3.99%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $153.63 -0.02 (-0.01%) 7:58 PM ET
2-Buy of 5 2
A Value B Growth F Momentum A VGM
Income Statements
Fiscal Year end for Universal Health Services, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 14,282 | 13,399 | 12,642 | 11,559 | 11,378 |
Cost Of Goods | 1,533 | 1,474 | 1,427 | 1,288 | 1,251 |
Gross Profit | 12,749 | 11,925 | 11,215 | 10,271 | 10,127 |
Selling & Adminstrative & Depr. & Amort Expenses | 11,574 | 10,921 | 9,852 | 8,912 | 8,911 |
Income After Depreciation & Amortization | 1,175 | 1,004 | 1,363 | 1,358 | 1,216 |
Non-Operating Income | -28 | -10 | 14 | 0 | 13 |
Interest Expense | 207 | 127 | 84 | 106 | 163 |
Pretax Income | 940 | 866 | 1,293 | 1,252 | 1,066 |
Income Taxes | 221 | 209 | 306 | 299 | 239 |
Minority Interest | 2 | -19 | -4 | 9 | 13 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 719 | 657 | 988 | 953 | 828 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 718 | 676 | 992 | 944 | 815 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,743 | 1,585 | 1,896 | 1,869 | 1,706 |
Depreciation & Amortization (Cash Flow) | 568 | 582 | 533 | 510 | 490 |
Income After Depreciation & Amortization | 1,175 | 1,004 | 1,363 | 1,358 | 1,216 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 70.13 | 73.83 | 83.69 | 85.59 | 89.04 |
Diluted EPS Before Non-Recurring Items | 10.54 | 9.88 | 11.82 | 11.12 | 9.99 |
Diluted Net EPS (GAAP) | 10.23 | 9.14 | 11.82 | 10.99 | 9.13 |
Fiscal Year end for Universal Health Services, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 3,703.55 | 3,562.77 | 3,548.14 | 3,467.52 |
Cost Of Goods | NA | 393.88 | 378.67 | 380.29 | 379.99 |
Gross Profit | NA | 3,309.67 | 3,184.11 | 3,167.84 | 3,087.53 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 2,978.47 | 2,898.76 | 2,887.71 | 2,808.83 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 331.20 | 285.35 | 280.13 | 278.70 |
Non-Operating Income | NA | 3.52 | -11.47 | -6.60 | -13.72 |
Interest Expense | NA | 53.59 | 53.38 | 48.83 | 50.88 |
Pretax Income | NA | 281.12 | 220.51 | 224.70 | 214.10 |
Income Taxes | NA | 61.50 | 52.50 | 55.39 | 51.73 |
Minority Interest | NA | 3.24 | 1.02 | -2.01 | -0.74 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 219.62 | 168.01 | 169.30 | 162.38 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 216.38 | 166.99 | 171.31 | 163.12 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 68.55 | 69.62 | 70.84 | 71.49 |
Diluted EPS Before Non-Recurring Items | NA | 3.13 | 2.55 | 2.53 | 2.34 |
Diluted Net EPS (GAAP) | NA | 3.13 | 2.40 | 2.42 | 2.28 |